160 related articles for article (PubMed ID: 8787871)
1. Activity of pyrazinamide in a murine model against Mycobacterium tuberculosis isolates with various levels of in vitro susceptibility.
Klemens SP; Sharpe CA; Cynamon MH
Antimicrob Agents Chemother; 1996 Jan; 40(1):14-6. PubMed ID: 8787871
[TBL] [Abstract][Full Text] [Related]
2. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
[TBL] [Abstract][Full Text] [Related]
3. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
4. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
Pina RZ; Caleffi-Ferracioli KR; Campanerut-Sá PA; Ghiraldi-Lopez LD; Pavan FR; Siqueira VL; Scodro RB; Cardoso RF
Int J Tuberc Lung Dis; 2016 Nov; 20(11):1535-1538. PubMed ID: 27776597
[TBL] [Abstract][Full Text] [Related]
7. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Heifets L; Sanchez T
J Clin Microbiol; 2000 Apr; 38(4):1498-501. PubMed ID: 10747133
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
9. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
11. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
12. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
13. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.
Takii T; Hamasaki S; Hirano K; Abe C; Onozaki K
Antimicrob Agents Chemother; 2005 Feb; 49(2):804-7. PubMed ID: 15673774
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
15. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
Mansjo M; Werngren J; Hoffner S
Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
[TBL] [Abstract][Full Text] [Related]
16. Correlation between resistance to pyrazinamide and resistance to other antituberculosis drugs in Mycobacterium tuberculosis strains isolated at a referral hospital.
Fonseca Lde S; Marsico AG; Vieira GB; Duarte Rda S; Saad MH; Mello Fde C
J Bras Pneumol; 2012; 38(5):630-3. PubMed ID: 23147056
[TBL] [Abstract][Full Text] [Related]
17. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test].
Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT
Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250
[TBL] [Abstract][Full Text] [Related]
19. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Permar S; Sun Z
J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
[TBL] [Abstract][Full Text] [Related]
20. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates.
Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y
J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
